None
Czechs expel more Russian diplomats in dispute over 2014 depot blast
Biogen talks up approval plans for controversial Alzheimer’s drug as it nears FDA decision
Zymergen stock indicated to open around $40.30, or 30% above IPO price
Lagarde Deems Tapering Talks ‘Premature’ as ECB Stays the Course
Canada Is Tapering Bond Purchases. What That Means for U.S. Markets.
BREAKING
Dow Inc., Walgreens Boots share losses lead Dow's 37-point drop
Credit Suisse executives were grilled on Archegos losses. Here’s what they said.
Credit Suisse taps shareholders for cash as regulator investigates Archegos losses
Global COVID cases top 144 million as India breaks U.S.’s daily case record
French vaccine maker Valneva launches Phase 3 trial of its COVID-19 shot after snubbing EU
How tiny ‘beach huts’ became the hottest commodity in British real estate
Virtual Stock Exchange